BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37733240)

  • 1. CD4 levels and NSCLC metastasis: the benefits of maintaining moderate levels.
    Bai Y; Liu Y; Wu J; Miao R; Xu Z; Hu C; Zhou J; Guo J; Xie J; Shi Z; Ding X; Xing Y; Hu D
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16827-16836. PubMed ID: 37733240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of lymphocyte subsets with efficacy and prognosis of immune checkpoint inhibitor therapy in advanced non-small cell lung carcinoma: a retrospective study.
    Yan Y; Wang X; Liu C; Jia J
    BMC Pulm Med; 2022 Apr; 22(1):166. PubMed ID: 35484541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for brain metastases from non-small-cell lung cancer: A protocol for observational study.
    He J; Wang X; Xiao R; Zuo W; Zhang W; Yao H
    Medicine (Baltimore); 2021 Mar; 100(9):e24724. PubMed ID: 33655937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship Between Neutrophil-To-Lymphocyte Ratio and Brain Metastasis in Non-Small Cell Lung Cancer Patients.
    Hu C; Wu J; Liu Y; Zhou J; Wang W; Wang X; Guo J; Wang Q; Zhang X; Li D; Xie J; Ding X; Xing Y; Hu D
    Cancer Control; 2022; 29():10732748221076805. PubMed ID: 35209734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk and prognostic factors of brain metastasis in lung cancer patients: a Surveillance, Epidemiology, and End Results population‑based cohort study.
    Hao Y; Li G
    Eur J Cancer Prev; 2023 Sep; 32(5):498-511. PubMed ID: 36804864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of osimertinib in EGFR-mutant non-small cell lung cancer with distant metastasis.
    Gen S; Tanaka I; Morise M; Koyama J; Kodama Y; Matsui A; Miyazawa A; Hase T; Hibino Y; Yokoyama T; Kimura T; Yoshida N; Sato M; Hashimoto N
    BMC Cancer; 2022 Jun; 22(1):654. PubMed ID: 35698083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High systemic immune-inflammation index is a predictor of poor prognosis in patients with nonsmall cell lung cancer and bone metastasis.
    Xu S; Cao S; Yu Y
    J Cancer Res Ther; 2021 Dec; 17(7):1636-1642. PubMed ID: 35381733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of the Human Lung and Gut Microbiomes in Non-Small Cell Lung Carcinomas and Distant Metastasis.
    Lu H; Gao NL; Tong F; Wang J; Li H; Zhang R; Ma H; Yang N; Zhang Y; Wang Y; Liang Z; Zeng H; Chen WH; Dong X
    Microbiol Spectr; 2021 Dec; 9(3):e0080221. PubMed ID: 34787462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic impact of lymph node metastasis in patients with non-small cell lung cancer and distant organ metastasis.
    Yang J; Peng A; Wang B; Gusdon AM; Sun X; Jiang G; Zhang P
    Clin Exp Metastasis; 2019 Oct; 36(5):457-466. PubMed ID: 31420766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors of postrecurrence survival in completely resected stage I non-small cell lung cancer with distant metastasis.
    Hung JJ; Jeng WJ; Hsu WH; Wu KJ; Chou TY; Hsieh CC; Huang MH; Liu JS; Wu YC
    Thorax; 2010 Mar; 65(3):241-5. PubMed ID: 20335294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of CD4+ T lymphopenia in non-small cell lung Cancer.
    Eberst G; Vernerey D; Laheurte C; Meurisse A; Kaulek V; Cuche L; Jacoulet P; Almotlak H; Lahourcade J; Gainet-Brun M; Fabre E; Le Pimpec-Barthes F; Adotevi O; Westeel V
    BMC Cancer; 2022 May; 22(1):529. PubMed ID: 35546670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impacts of extracranial metastasis on non-small cell lung cancer with brain metastasis: A retrospective study based on surveillance, epidemiology, and end results database.
    Wang M; Wu Q; Zhang J; Qin G; Yang T; Liu Y; Wang X; Zhang B; Wei Y
    Cancer Med; 2021 Jan; 10(2):471-482. PubMed ID: 33320433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and evaluation of a prognostic risk model of tumor metastasis-related genes in patients with non-small cell lung cancer.
    Ding H; Shi L; Chen Z; Lu Y; Tian Z; Xiao H; Deng X; Chen P; Zhang Y
    BMC Med Genomics; 2022 Sep; 15(1):187. PubMed ID: 36056349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the Survival Time in the Non-small Cell Lung Cancer Patients with Different Organ Metastasis].
    Wu B; Wei S; Tian J; Song X; Hu P; Cui Y
    Zhongguo Fei Ai Za Zhi; 2019 Feb; 22(2):105-110. PubMed ID: 30827327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of PET/CT uptake for peripheral clinical N0 non-small cell lung cancer.
    Wang S; Lin D; Yang X; Zhan C; Zhao S; Luo R; Wang Q; Tan L
    Cancer Med; 2020 Apr; 9(7):2445-2453. PubMed ID: 32056387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer.
    Liao S; Penney BC; Wroblewski K; Zhang H; Simon CA; Kampalath R; Shih MC; Shimada N; Chen S; Salgia R; Appelbaum DE; Suzuki K; Chen CT; Pu Y
    Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):27-38. PubMed ID: 21946983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma D-Dimer Level Correlates with Age, Metastasis, Recurrence, Tumor-Node-Metastasis Classification (TNM), and Treatment of Non-Small-Cell Lung Cancer (NSCLC) Patients.
    Guo J; Gao Y; Gong Z; Dong P; Mao Y; Li F; Rong J; Zhang J; Zhou Y; Feng H; Guo H; Gu L; An M; Wen K; Zhang J
    Biomed Res Int; 2021; 2021():9623571. PubMed ID: 34712737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Driver genes as predictive indicators of brain metastasis in patients with advanced NSCLC: EGFR, ALK, and RET gene mutations.
    Wang H; Wang Z; Zhang G; Zhang M; Zhang X; Li H; Zheng X; Ma Z
    Cancer Med; 2020 Jan; 9(2):487-495. PubMed ID: 31769228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors of postoperative recurrences in patients with clinical stage I NSCLC.
    Chen YY; Huang TW; Tsai WC; Lin LF; Cheng JB; Chang H; Lee SC
    World J Surg Oncol; 2014 Jan; 12():10. PubMed ID: 24410748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Real-world study on the efficacy and prognostic predictive biomarker of patients with metastatic non-small cell lung cancer treated with programmed death-1/programmed death ligand 1 inhibitors].
    Zhu WJ; Zhu HH; Liu YT; Lin L; Xing PY; Hao XZ; Cong MH; Wang HY; Wang Y; Li JL; Feng Y; Hu XS
    Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):416-424. PubMed ID: 35615798
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.